Threshold Pharmaceuticals, Inc. Stock price Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Financials (USD)
Sales 2023 * | 58.06M | Sales 2024 * | 22.73M | Capitalization | 12.68M |
---|---|---|---|---|---|
Net income 2023 * | -11M | Net income 2024 * | -28M | EV / Sales 2023 * | 0.22 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.56 x |
P/E ratio 2023 * |
-0.9
x | P/E ratio 2024 * |
-0.69
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 94.84% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Jason Kim
DFI | Director of Finance/CFO | 49 | 09-12-31 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Harold Selick
CHM | Chairman | 69 | 17-07-31 |
David Hoffmann
BRD | Director/Board Member | 79 | 17-07-31 |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.60% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |